Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/33017
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease |
Autor: | Adell, Albert CSIC ORCID ; Mengod Los Arcos, Guadalupe CSIC ORCID; Artigas, Francesc CSIC ORCID; Alberch, Jordi CSIC | Palabras clave: | Amphetamine Axonal transport Movement disorders Neuronal dysfunction Neurotrophins Substantia nigra |
Fecha de publicación: | jun-2005 | Editor: | Wiley-Blackwell | Citación: | Journal of Neurochemistry 93(5): 1057–1068 (2005) | Resumen: | Dysfunction of dopaminergic neurons may contribute to motor impairment in Huntington's disease. Here, we study the role of brain-derived neurotrophic factor (BDNF) in alterations of the nigrostriatal system associated with transgenics carrying mutant huntingtin. Using huntingtin-BDNF+/– double-mutant mice, we analyzed the effects of reducing the levels of BDNF expression in a model of Huntington's disease (R6/1). When compared with R6/1 mice, these mice exhibit an increased number of aggregates in the substantia nigra pars compacta. In addition, reduction of BDNF expression exacerbates the dopaminergic neuronal dysfunction seen in mutant huntingtin mice, such as the decrease in retrograde labelling of dopaminergic neurons and striatal dopamine content. However, mutant huntingtin mice with normal or lowered BDNF expression show the same decrease in the anterograde transport, number of dopaminergic neurons and nigral volume. In addition, reduced BDNF expression causes decreased dopamine receptor expression in mutant huntingtin mice. Examination of changes in locomotor activity induced by dopamine receptor agonists revealed that, in comparison with R6/1 mice, the double mutant mice exhibit lower activity in response to amphetamine, but not to apomorphine. In conclusion, these findings demonstrate that the decreased BDNF expression observed in Huntington's disease exacerbates dopaminergic neuronal dysfunction, which may participate in the motor disturbances associated with this neurodegenerative disorder. | Versión del editor: | http://dx.doi.org/10.1111/j.1471-4159.2005.03047.x | URI: | http://hdl.handle.net/10261/33017 | DOI: | 10.1111/j.1471-4159.2005.03047.x | ISSN: | 0022-3042 | E-ISSN: | 1471-4159 |
Aparece en las colecciones: | (IIBB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
60
checked on 30-mar-2024
WEB OF SCIENCETM
Citations
54
checked on 28-feb-2024
Page view(s)
429
checked on 22-abr-2024
Download(s)
115
checked on 22-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.